Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Finance

March 31 Quick Takes: Cowen leads €47M addition to AM-Pharma's C round; plus Zucara, CellFe, Zentalis and Shanghai Junshi

April 1, 2020 1:10 AM UTC

AM-Pharma raises $52M series C extension
AM-Pharma B.V. raised €47 million ($51.7 million) in an additional close of its series C round, bringing the total funds raised in the round to €163 million. The round was led by Cowen Healthcare Investments and the European Investment Bank. The company expects to start this half a Phase III trial of reCAP, a recombinant human alkaline phosphatase, to treat sepsis-associated-acute kidney injury (see “AM-Pharma Raises €116M Series C”).

Zucara raises $21M A round
Zucara Therapeutics Inc. raised $21 million in a series A round led by the Perceptive Xontogeny Venture Fund. The company plans to start a Phase I trial mid-year of SSTR2 antagonist ZT-01 to prevent hypoglycemia in patients with Type I diabetes; the funds will also support Phase II testing (see "Suppressing Somatostatin")...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article